Anlotinib for Esophageal Cancer (AFEC)
NCT04966611
·
clinicaltrials.gov ↗
UNKNOWN
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Esophageal Cancer
Interventions
DRUG:
Anlotinib
Sponsor
Anyang Tumor Hospital